Want FREE Templates on Organization, Change, & Culture? Download our FREE compilation of 50+ slides. This is an exclusive promotion being run on LinkedIn.

Marcus Insights
Pivoting Pharma: Embracing Digital Health and Personalized Medicine Trends

Need help finding what you need? Say hello to Marcus. Based on our proprietary MARC [?] technology, Marcus will search our vast database of management topics and best practice documents to identify the most relevant to your specific, unique business situation. This tool is still in beta. If you have any suggestions or questions, please let us know at support@flevy.com.

Role: Marketing Executive
Industry: Global Pharmaceutical Company

Situation: The market dynamics are shifting with increased demand for personalized medicine and digital health solutions, but our company's focus has remained on traditional drugs. Strengths: a strong R&D department and a global salesforce. Weaknesses: a conservative approach to market trends and a slow digital transformation process.

Question to Marcus:

What steps can we take to pivot our marketing strategy to embrace digital health solutions and personalized medicine trends?

Ask Marcus a Question

Based on your specific organizational details captured above, Marcus recommends the following areas for evaluation (in roughly decreasing priority). If you need any further clarification or details on the specific frameworks and concepts described below, please contact us: support@flevy.com.

Digital Transformation

As the Marketing Executive of a Global Pharmaceutical Company, embracing Digital Transformation is imperative to capitalize on the growing trend of personalized medicine and digital health solutions. Your strong R&D department could focus on integrating Big Data analytics to derive insights from vast datasets, such as genomic information, which can lead to more personalized healthcare solutions.

The global salesforce can be equipped with digital tools and CRM systems to better understand and predict customer needs, enabling more effective targeting and increased customer engagement. Leverage your R&D strength to innovate in digital health applications and platforms, which can complement your traditional drug offerings and drive growth in new segments.

Learn more about Digital Transformation Big Data

Change Management

Shifting towards personalized medicine and digital health requires significant Change Management. As your company has a conservative approach, it's crucial to develop a comprehensive change management strategy that communicates the benefits of digital health solutions to all stakeholders.

This involves aligning the organization's culture with a more Agile and risk-taking mindset. Engage your global salesforce as change agents by providing training that emphasizes the Value Proposition of personalized medicine. You should also foster a culture of continuous learning and adaptability, which are essential qualities for navigating the evolving healthcare landscape.

Learn more about Change Management Value Proposition Agile

Business Strategy Example

Your business strategy needs to evolve to address the shift towards personalized medicine. This involves conducting a Strategic Analysis to identify opportunities where digital health can enhance or complement your existing product lines.

Your strategy should prioritize investments in technologies that support personalized healthcare, such as AI, Machine Learning, and bioinformatics. Collaborate with technology partners to co-develop solutions, and consider strategic acquisitions to fill capability gaps quickly. Use your global salesforce to gather Market Intelligence that can inform your strategy and refine your offerings.

Learn more about Strategic Analysis Machine Learning Market Intelligence Business Strategy Example

Innovation Management

To stay ahead of market trends, your Innovation Management must focus on speed and agility. Encourage your R&D department to work on quick-win projects in digital health that can demonstrate value and build momentum for larger-scale initiatives.

Adopt a Lean Startup approach for new projects, which allows for rapid prototyping, testing, and iteration. This approach reduces the time to get feedback from the market and adjust accordingly, which is crucial in the fast-moving digital health space.

Learn more about Innovation Management Lean Startup

Strategic Planning

Your Strategic Planning should include a roadmap for integrating personalized medicine into your company's portfolio. Set clear milestones for the adoption of digital health initiatives and create cross-functional teams that leverage R&D and sales insights to drive these projects forward.

Reevaluate your current partnerships and Supply Chain to ensure they support the delivery of personalized solutions. Also, plan for regulatory changes that could affect the deployment of digital health services.

Learn more about Strategic Planning Supply Chain

Customer Experience

In the pharmaceutical industry, the Customer Experience is increasingly important. With patients seeking more personalized and convenient solutions, providing a seamless digital experience is becoming a key differentiator.

Invest in Customer-centric Design and build interactive platforms that allow for personalized interactions and services. Utilize Data Analytics to provide insights into patient behavior and preferences, enabling your global salesforce to deliver a more tailored and proactive service.

Learn more about Customer Experience Customer-centric Design Data Analytics

Supply Chain Resilience

Developing digital health solutions and personalized medicine will require adjustments to your supply chain. Work on enhancing Supply Chain Resilience by incorporating flexibility to manage highly personalized products, which may have unique manufacturing and distribution requirements.

Invest in technologies like IoT for better tracking and blockchain for improved transparency, ensuring the integrity and timely delivery of personalized treatments.

Learn more about Supply Chain Resilience

Market Segmentation

For a successful pivot, you must revisit your Market Segmentation strategy. Identify patient groups who are most likely to benefit from personalized medicine and digital health solutions.

Develop targeted marketing campaigns that speak to the specific needs and outcomes these segments are seeking. Leverage data-driven insights to refine your approach and customize your communication for each segment, maximizing the impact of your global salesforce.

Learn more about Market Segmentation

Customer Relationship Management

Enhance your Customer Relationship Management (CRM) capabilities to support the shift toward personalized medicine. Implement advanced CRM systems that can handle high volumes of patient data securely and comply with privacy regulations.

Use this data to personalize communication and improve patient engagement. Your salesforce should be trained to leverage this data to provide customized solutions and support for healthcare professionals and patients.

Learn more about Customer Relationship Management


Analytics will be a key enabler in your transition to personalized medicine. Implementing robust analytics systems will allow you to draw actionable insights from clinical data, patient feedback, and market trends.

This information can guide your R&D efforts, inform your marketing strategies, and help your salesforce understand and anticipate customer needs. Using analytics, you can refine your product offerings to better meet the demands of personalized healthcare.

Learn more about Analytics

Did you know?
The average daily rate of a McKinsey consultant is $6,625 (not including expenses). The average price of a Flevy document is $65.

How did Marcus do? Let us know. This tool is still in beta. We would appreciate any feedback you could provide us: support@flevy.com.

If you have any other questions, you can ask Marcus again here.

Trusted by over 10,000+ Client Organizations
Since 2012, we have provided best practices to over 10,000 businesses and organizations of all sizes, from startups and small businesses to the Fortune 100, in over 130 countries.
AT&T GE Cisco Intel IBM Coke Dell Toyota HP Nike Samsung Microsoft Astrazeneca JP Morgan KPMG Walgreens Walmart 3M Kaiser Oracle SAP Google E&Y Volvo Bosch Merck Fedex Shell Amgen Eli Lilly Roche AIG Abbott Amazon PwC T-Mobile Broadcom Bayer Pearson Titleist ConEd Pfizer NTT Data Schwab

Additional Marcus Insights